List of works - Hasan Jafri

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

scholarly article

A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients

scientific article published in March 2009

A systematic review of risk factors associated with surgical site infections among surgical patients

scientific article

Alternatives to antibiotics

scientific article

Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis.

scientific article

Antibody-based therapy to combat Staphylococcus aureus infections.

scientific article published on 5 March 2017

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia

scientific article

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

scientific article

Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey.

scientific article published in October 2007

Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

scientific article

Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial

scientific article published on 24 April 2009

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

scientific article published on 23 October 2015

Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.

scientific article published on 21 June 2015

Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.

scientific article published on March 2005

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection

scientific article

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

scientific article

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

scientific article

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

scientific article published on December 2007

MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

scientific journal article

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

scientific article published in March 2005

Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model

scientific article

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

scientific article

Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.

scientific article published on 15 December 2008

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children

scientific article

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation.

scientific article

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity.

scientific article

Respiratory Syncytial Virus Genotypes, Host Immune Profiles and Disease Severity in Young Children Hospitalized with Bronchiolitis

scientific article published on 17 October 2017

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

scientific article

Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

scientific article published on November 2008

Respiratory syncytial virus persistence: evidence in the mouse model.

scientific article published on October 2008

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model

scientific article

Safety experience with caspofungin in pediatric patients.

scientific article published on December 2009

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

scientific article

Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants.

scientific article published in December 2010

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

scientific article published in April 2008

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893

scientific article published on 20 June 2016

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin

scientific article

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

scientific article

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

scientific article published on August 2016

List of works by Hasan Jafri

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients

A systematic review of risk factors associated with surgical site infections among surgical patients

Alternatives to antibiotics

Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis.

Antibody-based therapy to combat Staphylococcus aureus infections.

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey.

Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.

Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation.

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity.

Respiratory Syncytial Virus Genotypes, Host Immune Profiles and Disease Severity in Young Children Hospitalized with Bronchiolitis

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

Respiratory syncytial virus persistence: evidence in the mouse model.

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model

Safety experience with caspofungin in pediatric patients.

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants.

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia